3 Marijuana Stocks to Consider Buying in April

As we head into April, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) is looking like one of the best pot stocks out there.

| More on:
edit Jars of marijuana

Image source: Getty Images

Heading into April, the marijuana industry is once again on the rise. After a terrible end to 2018, Canada’s pot stocks are going up, with many of them approaching last year’s highs. Following encouraging Q3 results from Canopy, there’s a renewed sense of optimism about the marijuana industry. This time, however, it’s not necessarily Canopy that’s stealing the spotlight.

If you’re looking to add some marijuana stocks to your portfolio in April, the following three rising stars could make excellent picks.

Aurora Cannabis (TSX:ACB)(NYSE:ACB)

Aurora Cannabis has been getting a lot of press this month. After rolling out its retail strategy, naming billionaire Nelson Peltz as an advisor, and rising 36% in the markets, it’s been on a major winning streak.

The latest data out of Aurora compares unfavourably to Canopy’s glowing Q3 report. Whereas Canopy posted $73 million in earnings, Aurora swung back from a big profit to a massive loss. However, marijuana companies’ earnings are often influenced by fair-value appraisals and financing factors more so than operational results, so the disparity needn’t necessarily mean much.

In the meantime, Aurora has completed a major acquisition that will dramatically increase its retail pipeline, providing a missing link that could help it compete with Canopy.

CannTrust Holdings (TSX:TRST)(NYSE:CTST)

CannTrust has long been one of the more profitable marijuana companies, owing to its lean operations and relative lack of acquisition hunger. It’s also been one of the biggest risers in its industry, up 79% year to date. At a time when most marijuana stocks are dizzyingly expensive, CannTrust trades at just 70 times earnings (that’s high for most stocks but low for a high-growth stock like this one).

Cronos Group (TSX:CRON)(NASDAQ:CRON)

So far in 2019, Cronos Group’s stock has more than doubled, making it one of the bigger marijuana risers this year. It’s not hard to see why this stock is on fire. After receiving a $1.8 billion investment from Altria, the company arguably has more “smart money” backing than any marijuana producer that’s not Canopy.

On top of that, Cronos Group has one of the better profitability histories among marijuana stocks. Although it’s not consistently net and operationally profitable like CannTrust, its earnings history has a number of profitable quarters — a milestone that not every marijuana company has achieved.

Analyst sentiment toward Cronos group is pretty negative at the moment, with an average target price of $20.30 (the stock trades for $21.70 as of this writing). Analysts point to a high valuation as a point of concern, as the stock trades at about 80 times EBITDA estimates. Cronos is indeed an expensive stock. However, high P/E ratios never stopped marijuana stocks from rising before. As these stocks are mostly speculative sentiment plays, it might be better to use growth figures when picking stocks in the pot industry.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Andrew Button has no position in any of the stocks mentioned.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »